Spotlight on Antibodies | Episode 7 | July 1 - 31, 2025 Latest Developments in High Titer Transient Protein Expression using the ExpiCHO DIMA Biotech specializes in expressing and purifying membrane proteins using mammalian cells. Our extensive inventory
In this webinar, Dr. Marayna Löwe and Dr. Mathieu Schaff will provide valuable knowledge and practical insights into copolymers Discovery Challenges & Strategies - Targeting Membrane Proteins
Scientist Stories: Andrew Kruse, GPCRs & Antibody Discovery COVID-19 mutant variants | Biology Solutions | High-Throughput Antibody Screening | LSA Platform Originally presented at the Antibody Engineering & Therapeutics Digital Week on June 8-10, 2020. Watch this and the other
Speaker: Dr. Nathan Robertson I Group Leader — Antibody Discovery/Protein Engineering I OXGENE Antibody screening using Unlocking Biomarker Discovery with Multiplex Antibody Membrane Arrays 🚀 | Assay Genie Antibody Therapies Targeting Complex Membrane Proteins
In this webinar, we introduce single cell technology in immunology and antibody screening, including its emergence, various Generating protein reagents to evaluate the antibody and CD8+ T cell responses to SARS-CoV-2 Abstract Transmembrane proteins usually play pivotal roles in various cellular processes, including signal transduction, cell
This presentation, delivered at CAS 2025 and presented by DIMA Biotech, highlights our proprietary platform for the discovery of Improving Drug Discovery: A Molecular Understanding of Cell Receptors (Short) A technology for illuminating proteins on the cell surface promises to boost the success of drug discovery, aid in basic research,
Dr. Mike Taussig, Cambridge Protein Arrays, and Dr. Fridtjof Lund-Johansen, Oslo University Hospital, look at array and [GEN Webinars] Towards IND: Specificity Profiling of Antibody-Based Therapies 6 Steps to Success in Discovering Monoclonal Antibodies Against Multipass Membrane Proteins
Antibody Discovery | Integral Molecular Presented by Carterra and Bio-Techne The COVID-19 pandemic and global effort around vaccine development has heightened
Immunogens with native conformation and a high-throughput IgG cloning platform are two of the most important key components The human animal is multicellular – an organism comprised of trillions of smaller organisms. As with any complex organisation,
Targeting membrane proteins for antibody discovery using phage De-Risking Antibody Lead Selection: Is your antibody as specific as you think? by Ben Doranz, PhD Comprehensive Specificity Profiling of Antibody-Based Therapeutics Using the Membrane Proteome Array
Using AI and Synthetic Biology to Go Where Antibody Therapies Can’t Accelerate COVID19 Antibody Discovery With ProSpeed Single B Cell Technology
Overview of the CRO Service Platforms for Recombinant Protein Expression and Antibody Development MPSA-AB5000 is a high-throughput cell-based platform for identifying the targets of antibodies and other ligands that bind to membrane proteins. Off-target binding remains a major challenge in antibody development, often leading to safety concerns and failed programs.
Cracking Protein Structures: From Cryo-EM to Antibody Discovery – A Webinar with Dr. Krishna Bhat Part 1: Identification of Monoclonal Antibodies that Block Ion Channel Activity Learn how Tetragenetics has developed a strategy To help Biopharm accelerate its pace on pre-clinical antibody drug lead selection, DIMA Biotech launched an “All Druggable
Join us live for our webinar, in collaboration with Drug Target Review. Our Chief Technology Officer, Xavier Leroy and Martine Visit the Proteomics Analytics Resource Center: In this webinar, Jeffrey Silva, PhD, Principal Join us for an exclusive session with Dr. Krishna Bhat, Principal Scientist at IONLACE and former researcher at Umeå University
Stabilization of native & functional membrane proteins for drug discovery Webinar: Best Practices for Antibody Specificity Testing for IND Submissions Transient expression is a fast and reliable way to generate recombinant antibodies and proteins (i.e. products) for all research
The successful isolation of antibodies from a naive scFv library is described for three membrane bound proteins; human CD83, canine CD117 and bat CD11b. Breaking barriers in antibody discovery: harnessing divergent The discovery and challenges of antibodies targeting GPCRs
Protein Science in Drug Discovery Presented By: Natalia Guadalupe Herrera Speaker Biography: My name is Natalia Guadalupe Herrera and I obtained a BS in
Complex integral membrane proteins, which are embedded in the cell surface lipid bilayer by multiple transmembrane spanning polypeptides, encompass families The development of antibody drugs has greatly depended on the establishment of new technologies and platforms, which are
Everyday researchers face the daunting challenge of creating more effective biotherapeutics. Many candidates fail due to a lack of Antibody discovery in weeks versus years - Isolate, culture, and assay tens of thousands of single cells with the Beacon platform
This is the second episode of the second season of the DISCOVER MOLECULAR INTERACTIONS webinar series. Each month Accelerating the Antibody Discovery Workflow in the Modern Therapeutic Landscape Webinar: Uni-Select™ Mammalian Cell-Based Membrane Proteins Antibody Screening Applied StemCell provides Custom
Using Single B Technology to Develop Lead Antibody Molecules on GPCR Targets Presented At: LabRoots - Gibco ExpressionWorld 2017 Presented By: Jon Zmuda, PhD - Director, Cell Biology, Life Sciences Presented By: Dr. Donghui Ma Speaker Biography: Dr. Donghui Ma, an accomplished biotechnology pioneer, serves as the
ChemPartner Webinar: Rapid Discovery of a Diverse Panel of Antibodies Against Membrane Targets The current review focuses on the ways in which therapeutic antibody discovery and development technologies are evolving the possibilities for antibody-based
Improve therapeutic monoclonal antibody selection by knowing protein stability using Prometheus Integral Molecular has a 95% success rate of discovering high-affinity monoclonal antibodies against multipass membrane Despite the remarkable growth of antibody-based therapies in recent years, numerous promising targets remain untapped.
Membrane Protein Antibody Discovery, MPS AB5000 | Kyinno Bio Discovery On Target 2020: Isolation of state-dependent monoclonal antibodies against GLUT4 The 13th Annual Antibodies Against Membrane Protein Targets brings together leading researchers and industry innovators to tackle the unique challenges and
Webinar "Next Gen P2X4 Antibody Discovery Enabled by the NativeMP+Phage Display Technology " DISCOVER pure protein-DNA conjugates: preparation, purification, and analysis with the proFIRE® Dispensable loops shield the functionally-important extracellular loops of the essential Gram-negative bacterial outer membrane protein LptD
Antibody drug development challenges & solutions This is the fourth episode of our DISCOVER MOLECULAR INTERACTIONS webinar series. Each month we will talk about
Webinar: AbDrop™ Speeds: Accelerating Your Antibody Discovery with Single B Solution Speaker: Gang Liu, Ph.D., Associate The MPS Discovery Engine® enables the isolation of monoclonal antibodies targeting complex membrane proteins. Click here to learn more. TARGATT A Mammalian Cell Library System for Antibody Protein Screening
Therapeutic mAb Discovery for Multi-Pass Transmembrane Protein Targets | DIMA Biotech @ CAS 2025 Complexities of using membrane proteins as antigens in antibody drug discovery, intrinsic challenges & innovative strategies for success.
Rigorous specificity analysis is critical for successful drug development and a safety requirement for monoclonal antibody (mAb) David MacMillan: A “flashlight” to identify cellular proteins for drug discovery Therapeutic lead antibody discovery and solutions
This webinar assembles experts in antibody discovery and development and features presentations from Integral Molecular, Antibodies Against Membrane Protein Targets | Discovery on Target PEGS Boston Virtual 2020 Presentation: De-Risking Antibody Lead Selection: Is your antibody as specific as you think? by Ben
Revolutionizing Drug Development: Synthetic Nanodiscs Spotlight on Antibodies is a podcast from Biointron ( , where we bring you the latest antibody Review: Membrane protein nanodiscs for antibody discovery
De Novo Design of Epitope-Specific Antibodies for Membrane Proteins with High Specificity & Function Antibody discovery at the edge of impossible
Presented At: LabRoots - Gibco ExpressionWorld 2017 Presented By: Anass Jawhari, PhD - Chief Scientific Officer, CALIXAR Protein Science in Drug Discovery Moderators: Vanita D. Sood, EMD Serono & Christopher Koth, Genentech Speakers: Patrick
Presented By: François Romagné Speaker Biography: Professor of immunotechnology at Aix-Marseille University (AMU), Antibody Validation 08: Protein arrays and mass spectrometry Multiple Innovative Technologies & Platforms Empower Antibody Discovery
Webinar: AbDrop™: Accelerating Your Antibody Discovery with Single B Solution | 2025 Take a tour of our latest antibody discovery workflow, Opto Plasma B Discovery 4.0.
This review discusses various membrane protein nanodiscs, and their applications in antibody discovery, alongside current advancements and challenges. Targeting Transmembrane Proteins: Facilitating Rapid Advancement in Therapeutic Antibody Discovery Integrated antibody discovery solution for multi-pass transmembrane target
Lessons in Generating Monoclonal Antibodies against Multipass Membrane Proteins- Ross Chambers, PhD Massive antibody discovery used to probe structure–function To exploit highly conserved and difficult drug targets, including multipass membrane proteins, monoclonal antibody discovery efforts increasingly rely on the
Are you working on antibody drug development with a challenging target, such as membrane proteins (e.g. GPCRs and ion Sino Biological is a leading manufacturer of recombinant proteins and antibodies. In addition to our biggest validated recombinant PEGS Virtual 2020 Presentation: Integral Molecular has a 95% success rate of discovering high-affinity monoclonal antibodies
Speakers: Andrew Hunt, Phd Student, Northwestern University Alex Pierson, Technical Product Manager for the Access Solutions 2025-08-21-DIMA: The Application of Synthetic Nanodisc Technology in Therapeutic Antibody Discovery Isolation of state-dependent monoclonal antibodies against the 12-transmembrane domain SLC2A4 glucose transporter (GLUT4 )
High Throughput Characterization of Ion Channel Activity Blocking mAbs with Array SPR | LSA Platform Targeting Proteomics to Decipher Biology for the Drug Development Pipeline
Webinar - New Ways to Boost Recombinant Protein and Antibody Yields in Transient Systems Advancements in AI are revolutionizing antibody design, enabling the creation of epitope-specific antibodies with exceptional
DISCOVER complex membrane targets: measure binding to GPCRs, ion channels and more directly on cells Dr Sachdev Sidhu Accelerating Antibody Discovery with Cell Free Protein Synthesis and Automation
PRODUCT: Opto Plasma B Discovery 4.0 Product Tour Discovery of Therapeutic Antibodies Targeting Complex Multi Webinar: Conquering Undruggable Targets to Obtain Preclinical Antibodies
Signal transduction across cell membranes plays a central role in human physiology and disease, yet the mechanistic details Looking to streamline your biomarker discovery process? In this video, we dive deep into Assay Genie's Membrane Antibody
Discovery of Potent anti-PD-L1 Antibodies | High-Throughput Antibody Screening | LSA Platform Monoclonal antibodies have been an important addition to the biomedical arsenal, but these therapies have limited ability to